激活PRKG1变体增强了光滑肌肉细胞的可变性,从而引起动脉缩症
Marie E Jost1, Moyra Schweizer1, Philipp Henning2
1Department of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
JACC. Basic to translational science
|January 16, 2026
概括
在PRKG1中罕见的遗传变异可以通过增加组织弹性引起大动脉剖析. 血管光滑肌细胞中的V219I变异导致更大,更容易变形的细胞和结构完整性的削弱,解释了这种情况的倾向.
科学领域:
- 心血管生物学 心血管生物学
- 遗传学 是一个遗传学.
- 分子医学是分子医学.
背景情况:
- 大动脉剖析通常与衰老和高血压有关.
- 罕见的遗传变异正在成为大动脉疾病的关键因素.
- PRKG1基因在血管光滑肌肉细胞功能中发挥作用.
研究的目的:
- 研究PRKG1 V219I基因变异在大动脉剖析中的作用.
- 阐明PRKG1变异使个体易患大动脉动脉瘤和剖析的分子机制.
- 了解PRKG1 V219I变异引起的细胞和结构变化.
主要方法:
- 对患有大动脉动脉瘤和PRKG1 V219I变异的患者的分析.
- 在体外研究中使用表达V219I变异的血管光滑肌细胞.
- 评估细胞大小,可变形性,actin细胞骨架动力学和细胞外矩阵信号传递.
主要成果:
- 血管光滑肌细胞与V219I变体更大,更容易变形.
- 观察到异常的actin细胞骨动力学和改变的细胞外矩阵信号.
- 这些变化导致结构完整性减弱,组织弹性增加.
结论:
- 这种PRKG1 V219I变异导致血管光滑肌肉细胞特性发生显著变化.
- 由于PRKG1变异而增加的组织弹性是大动脉剖析的关键病理机制.
- 这项研究提供了PRKG1相关的大动脉疾病的机制模型.
相关概念视频
Atherosclerosis I: Introduction
925
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
925
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Nitric Oxide Signaling Pathway
6.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.2K


